Document Detail

Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction.
MedLine Citation:
PMID:  21674595     Owner:  NLM     Status:  Publisher    
OBJECTIVES: Neurogenic bladder dysfunction has a negative impact on the patient's quality of life (QoL). Cystectomy with ileal conduit urinary diversion is a treatment option in patients in failure after conservative management. The objective of this study was to evaluate the impact of ileal conduit urinary diversion on the QoL of patients with neurogenic bladder dysfunction. MATERIALS AND METHODS: From March 2004 to November 2010, 48 patients (36 women and 12 men with a mean age of 50.6 ± 11.8 years) treated by cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction, prospectively completed, before and after surgery, two self-administered QoL questionnaires. Neurological diseases were multiple sclerosis in 38 cases, spinal cord injury in 7 cases, and other neurological disease in 3 cases. Cystectomy was performed by laparoscopy in all patients. QoL was measured by using two self-administered questionnaires, one questionnaire specific for urinary disorders validated in neurological patients, Qualiveen®, and the generic SF36-v2® questionnaire. Data were compared by Student's t test. RESULTS: Comparison of the Qualiveen® self-administered questionnaire scores and indices before and after surgery showed that, after surgery, patients presented a significant reduction of limitations (0.57 ± 0.64 vs. 1.55 ± 1.35, P < 0.001), constraints (2.12 ± 0.83 vs. 2.64 ± 1.12, P = 0.046) scores and the SIUP index (1.29 ± 0.65 vs. 1.79 ± 0.95, P = 0.015). No significant change in SF36-v2® scores was observed postoperatively. CONCLUSIONS: Ileal conduit urinary diversion improves the urinary QoL of patients with neurogenic bladder dysfunction by decreasing limitations and constraints induced by urinary disorders, but has no impact on general QoL. Neurourol. Urodynam. © 2011 Wiley-Liss, Inc.
J Guillotreau; E Castel-Lacanal; M Roumiguié; B Bordier; N Doumerc; X De Boissezon; B Malavaud; Ph Marque; P Rischmann; X Gamé
Related Documents :
22044745 - Red blood cell transfusion and increased length of storage are not associated with deep...
25412095 - Newly designed, fully covered metal stents for endoscopic ultrasound (eus)-guided trans...
25172965 - Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibri...
1806505 - Reversed dynamic slings: results of use in the treatment of post-traumatic flexion cont...
25331655 - Differences in component and limb alignment between computer-assisted and conventional ...
19201775 - Adalimumab for the treatment of fistulas in patients with crohn's disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-14
Journal Detail:
Title:  Neurourology and urodynamics     Volume:  -     ISSN:  1520-6777     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8303326     Medline TA:  Neurourol Urodyn     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Wiley-Liss, Inc.
Service d'Urologie, d'Andrologie et de Transplantation Rénale, CHU Rangueil, Toulouse, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Variability of urodynamic parameters in patients with overactive bladder.
Next Document:  Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neurom...